Skip to main content
letter
. 2023 Jul 18;9(3):e096. doi: 10.1097/JW9.0000000000000096

Fig. 1.

Fig. 1.

Perceptions of dermatologists on topical agents for acute hidradenitis suppurativa (HS) flares.